Alsanea Nasser, Almadi Majid A, Abduljabbar Alaa S, Alhomoud Samar, Alshaban Taghreed A, Alsuhaibani Abdullah, Alzahrani Ahmad, Batwa Faisal, Hassan Abdul-Hameed, Hibbert Denise, Nooh Randa, Alothman Mohammed, Rochwerg Bram, Alhazzani Waleed, Morgan Rebecca L
Nasser Alsanea, MBBCh, President, Saudi Society of Colon & Rectal Surgery,, Head Section, Colon & Rectal Surgery,, King Faisal Specialist Hospital & Research Centre-Riyadh, (MBC-40), PO Box 3354, Riyadh 11211,, Saudi Arabia, T: 966-1-442 7754, F: 966-1-442.7772,
Ann Saudi Med. 2015 May-Jun;35(3):189-95. doi: 10.5144/0256-4947.2015.189.
Colorectal cancer is the most common cancer among Saudi men and the third commonest among Saudi women. Given the predominance of colorectal cancer compared with other cancers in Saudi Arabia, context-specific guidelines are needed for screening.
Experts from the Saudi Society of Colon and Rectal Surgery, Saudi Gastroenterology Association, Saudi Oncology Society, Saudi Chapter of Enterostomal Therapy, Family Medicine and Department of Public Health at the Saudi Arabian Ministry of Health and a patient advocate was assembled by the Saudi Centre for Evidence-Based Healthcare, a subsidiary of the Saudi Arabian Ministry of Health. The panel collaborated with a methodological team from McMaster University, Canada to develop national guidelines for colorectal cancer screening. After identifying key questions, the panel conducted a systematic review of all reports on the utility of screening, the cost of screening for colorectal cancer in Saudi Arabia and on the values and preferences of Saudi patients. Meta- analyses, when appropriate, were performed to generate pooled estimates of effect. Using the GRADE approach, the panel used the evidence-to-decision (EtD) framework to assess all domains important in determining the strength and direction of the recommendations (benefits and harms, values and preferences, resource implications, equity, acceptability, and feasibility). Judgments related to the EtD domains were resolved through consensus or voting, if consensus was not reached. The final recommendations were developed during a two-day meeting held in Riyadh, Saudi Arabia in March 2015. Conflicts of interests among the panel members were handled according to the World Health Organization rules.
There is lack of national data on the incidence of adenomatous polyps or the age groups in which the incidence surges. There were no national clinical trials assessing the effectiveness of the different modalities of screening for colorectal cancer and their impact on mortality.
The panel recommends screening for colorectal cancer in Saudi Arabia in asymptomatic Saudi patients at average risk of colorectal cancer. An infrastructure should be built to achieve that goal.
结直肠癌是沙特男性中最常见的癌症,在沙特女性中是第三常见的癌症。鉴于在沙特阿拉伯结直肠癌比其他癌症更为普遍,需要有针对具体情况的筛查指南。
沙特结肠和直肠外科学会、沙特胃肠病学协会、沙特肿瘤学会、沙特造口治疗分会、家庭医学以及沙特阿拉伯卫生部公共卫生司的专家,以及一名患者权益倡导者,由沙特阿拉伯卫生部下属的沙特循证医疗中心召集。该小组与来自加拿大麦克马斯特大学的一个方法学团队合作,制定结直肠癌筛查的国家指南。在确定关键问题后,该小组对所有关于筛查效用、沙特阿拉伯结直肠癌筛查成本以及沙特患者的价值观和偏好的报告进行了系统综述。在适当情况下进行荟萃分析以生成效应的汇总估计值。使用GRADE方法,该小组采用证据到决策(EtD)框架来评估在确定建议的强度和方向时所有重要的领域(益处和危害、价值观和偏好、资源影响、公平性、可接受性和可行性)。如果未达成共识,与EtD领域相关的判断通过共识或投票解决。最终建议是在2015年3月于沙特阿拉伯利雅得举行的为期两天的会议上制定的。小组成员之间的利益冲突按照世界卫生组织的规则处理。
缺乏关于腺瘤性息肉发病率或发病率激增的年龄组的全国性数据。没有全国性临床试验评估不同结直肠癌筛查方式的有效性及其对死亡率的影响。
该小组建议对沙特阿拉伯患结直肠癌平均风险的无症状患者进行结直肠癌筛查。应建立基础设施以实现这一目标。